Table 3.
Clinical outcomes of patients.
| Outcomes | All patients (n = 37) | Duration from onset to release from quarantine | ||
|---|---|---|---|---|
| ≤20-day (n = 19) | >20-day (n = 18) | P-value | ||
| Hospitalization duration (d) | 16.1 ± 6.2 | 12.4 ± 3.7 | 20.1 ± 5.8 | 0 |
| Duration from onset to release from quarantine (d) | 20.2 ± 6.6 | 15.1 ± 3.4 | 25.6 ± 4.4 | 0 |
| Blood findings at the time of release from quarantine | ||||
| WBC <4.0 × 109/L (%) | 6/37 (16.2) | 2/19 (10.5) | 4/18 (22.2) | 0.405 |
| L <1.1 × 109/L (%) | 22/37 (59.5) | 10/19 (52.6) | 12/18 (66.7) | 0.508 |
| L ≤ 0.6 × 109/L (%) | 4/22 (18.2) | 2/10 (20.0) | 2/12 (16.7) | 1 |
| SAA>10 mg/L (%) | 5/37 (13.5) | 3/19 (15.8) | 2/18 (11.1) | 1 |
WBC, white blood cells; L, lymphocytes; SAA, serum amyloid A.